The Maternal Immune Axis Programs Fetal Corticogenesis
NIMH - National Institute of Mental Health
About This Grant
Project Summary This project seeks to elucidate sex-specific mechanisms by which maternal immune activation (MIA) during pregnancy impacts cortical development and elevates the risk for neurodevelopmental disorders (NDDs), focusing specifically on the CXCR7 (Ackr3)/CXCL12 chemokine signaling axis. MIA, triggered by maternal infection or inflammation, is a known risk factor for conditions such as autism spectrum disorder and schizophrenia, with male offspring often showing increased vulnerability and differing symptom profiles compared to females. The molecular basis of these sex differences remains poorly understood, representing a critical knowledge gap in both developmental neurobiology and translational medicine. Aim 1 will investigate the physiological role of the CXCR7/CXCL12 axis in corticogenesis, examining how sex-specific regulation of CXCR7 affects neural progenitor cell (NPC) differentiation and migration. By employing Ackr3 knockout models and epigenetic profiling, we will determine how CXCR7 signaling is modulated in male and female NPCs, which may underlie differences in cortical organization between the sexes. Aim 2 will examine the pathophysiological role of CXCR7/CXCL12 in response to MIA, testing the hypothesis that MIA induces a male-specific upregulation of CXCR7 that leads to aberrant cortical development and behaviors associated with NDDs. We will use advanced molecular techniques to assess how CXCR7 activation in males contributes to cortical disorganization, precocious NPC maturation, and behavioral changes, as well as to evaluate the dependency of these effects on maternal IL-17 signaling. Together, these aims will provide mechanistic insights into how intrinsic sex differences interact with environmental factors like MIA to shape brain development and vulnerability to NDDs. This work is significant because it addresses an urgent need to understand how intrinsic sex differences and external maternal immune influences jointly shape neurodevelopmental trajectories. This research ultimately aims to bridge a gap in neurodevelopmental disorder research by providing a clearer understanding of how male and female brains respond differently to environmental stressors during critical periods of development, which may have lasting implications for public health and clinical care.
Grant Summary
The Maternal Immune Axis Programs Fetal Corticogenesis is a NIMH - National Institute of Mental Health grant providing up to $689K for university, nonprofit, healthcare org. Applications are due 2031-01-31 (open). Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $689K
2031-01-31
- 1Confirm your organization is eligible for The Maternal Immune Axis Programs Fetal Corticogenesis from NIMH - National Institute of Mental Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIMH - National Institute of Mental Health before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIMH - National Institute of Mental Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
The Maternal Immune Axis Programs Fetal Corticogenesis: Frequently Asked Questions
Who is eligible for the The Maternal Immune Axis Programs Fetal Corticogenesis?
The Maternal Immune Axis Programs Fetal Corticogenesis is offered by NIMH - National Institute of Mental Health and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the The Maternal Immune Axis Programs Fetal Corticogenesis provide?
The Maternal Immune Axis Programs Fetal Corticogenesis provides up to $689K per award from NIMH - National Institute of Mental Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the The Maternal Immune Axis Programs Fetal Corticogenesis deadline?
Applications for The Maternal Immune Axis Programs Fetal Corticogenesis are due 2031-01-31 (open). Because deadlines can change, verify the date with the funder, NIMH - National Institute of Mental Health, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the The Maternal Immune Axis Programs Fetal Corticogenesis?
To apply for The Maternal Immune Axis Programs Fetal Corticogenesis, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIMH - National Institute of Mental Health.